Design
Review
Authors
Loading...
Conventional anticoagulants remain thrombosis therapy mainstay; Level 5 data leaves open their role versus newer agents in current practice.
Conventional anticoagulants including unfractionated heparin, LMWHs, and VKAs are established therapies for thrombosis with specific monitoring requirements and adverse event profiles.
Chrysa B. Kalkana (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: